Understand the source comparison
Thymalin Dosage Protocol: Research Use Comparison
Immune Senescence 10mg 20 days Daily Morning (8–10 AM) Thymic function restoration, T-cell population rebalancing in aging models Acute Immune Support 5–10mg 10 days Post-infection recovery, short-term immune enhancement Autoimmune Modulation 5mg 20–30 days Ev
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Immune Senescence
- 10mg
- 20 days
- Daily
- Morning (8–10 AM)
- Thymic function restoration, T-cell population rebalancing in aging models
- Acute Immune Support
- 5–10mg
- 10 days
- Post-infection recovery, short-term immune enhancement
- Autoimmune Modulation
- 5mg
- 20–30 days
- Every other day
- Evening (6–8 PM)
- Regulatory T-cell upregulation, inflammation reduction
- Thymic Regeneration
- 15–20mg
- 10–14 days
- Intensive thymosin-alpha-1 elevation, CD4:CD8 ratio correction
- Maintenance (Post-Cycle)
- Indefinite
- 2–3x weekly
- Sustained thymic peptide levels after initial restoration cycle
- Higher doses (15–20mg) are reserved for intensive research protocols where rapid thymic peptide elevation is the primary endpoint. Most standard research uses 10mg daily for 20 days as the foundational protocol, which consistently produces measurable T-cell population shifts without oversaturating thymic receptors. Injection timing aligns with natural cortisol rhythm. Morning administration (8–10 AM) works synergistically with the cortisol peak that occurs 30–60 minutes after waking, while evening administration may be preferred in autoimmune research where cortisol suppression is part of the therapeutic mechanism.